Changes in middle ear transmission characteristics secondary to altered bone remodelling.
Absorptiometry, Photon
/ methods
Acoustic Impedance Tests
/ methods
Adult
Aged
Audiometry, Pure-Tone
/ methods
Bone Density
/ physiology
Bone Diseases, Metabolic
/ complications
Bone Remodeling
/ physiology
Case-Control Studies
Ear, Middle
/ physiopathology
Female
Hearing Loss, Conductive
/ diagnosis
Humans
Male
Middle Aged
Osteoporosis
/ complications
Reflex, Acoustic
/ physiology
Middle ear
Osteopenia
Osteoporosis
Journal
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
ISSN: 1433-2965
Titre abrégé: Osteoporos Int
Pays: England
ID NLM: 9100105
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
received:
11
12
2017
accepted:
02
01
2019
pubmed:
18
1
2019
medline:
18
12
2019
entrez:
18
1
2019
Statut:
ppublish
Résumé
Alteration in the process of bone remodelling results in conditions like osteopenia and osteoporosis in which the bones become susceptible to fracture. The functioning of middle ear bones in such individuals were assessed in this study and it was found that the middle ear bones are equally susceptible to micro-fractures and can cause reduction in the transmission of sound energy. Alteration in the process of bone remodelling or increase in the number of osteoclasts cells as it occurs in osteoporosis and osteopenia are likely to affect the middle ear bones in the same way it affects the skeletal bones. Whether these micro-structural changes occurring at the level of the middle ear secondary to altered bone remodelling cause any significant impairment in its functioning is not explored. Thus, the present study aimed at assessing the different aspects of middle ear functioning in individuals with reduced BMD. The study included 25 normal, 39 osteopenic and 40 osteoporotic participants. The participants underwent pure-tone audiometry, otoscopic examination, conventional immittance evaluation using a 226 Hz probe tone, multi-component and multi-frequency tympanometry and acoustic reflex threshold testing. None of the participants had any current or previous history of middle ear effusion. A significantly higher proportion of participants in the clinical group had hearing loss compared to the normal group. The clinical group participants also had reduced middle ear resonance frequency, elevated static compliance values and elevated or absent acoustic reflexes compared to the normal participants. There was no difference among the three groups for the proportion of participants having conductive hearing loss. There is a detrimental impact of reduction in bone mineral density on middle ear transmission characteristics which may go unnoticed initially. Treatment of osteoporosis may potentially mitigate hearing loss from middle ear fractures due to reduced bone mineral density. Absence of significant air-bone gap with the presence of reduced middle ear resonance frequency may be early signs of reduced BMD.
Identifiants
pubmed: 30652218
doi: 10.1007/s00198-019-04834-w
pii: 10.1007/s00198-019-04834-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
863-870Subventions
Organisme : AIISH Research Fund, Ministry of Health and Family Welfare, Government of INDIA
ID : ARF Project No:10; 2016-2017
Références
Ann Otol Rhinol Laryngol. 1975 Jul-Aug;84(4 Pt 3 Suppl 22):1-32
pubmed: 1080381
J Am Acad Audiol. 1999 Apr;10(4):173-9
pubmed: 10941708
J Laryngol Otol. 2004 Aug;118(8):617-21
pubmed: 15453937
Nat Neurosci. 2005 Feb;8(2):149-55
pubmed: 15643426
J Clin Invest. 2005 Dec;115(12):3318-25
pubmed: 16322775
Bone. 2006 Aug;39(2):414-9
pubmed: 16564235
Bone. 2007 Apr;40(4):1060-5
pubmed: 17223616
Postgrad Med J. 2007 Aug;83(982):509-17
pubmed: 17675543
Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235
pubmed: 18088161
QJM. 2008 Aug;101(8):605-17
pubmed: 18334497
Acta Otorhinolaryngol Ital. 2008 Apr;28(2):61-6
pubmed: 18669069
Clin J Am Soc Nephrol. 2008 Nov;3 Suppl 3:S131-9
pubmed: 18988698
Ann Otol Rhinol Laryngol Suppl. 1990 Mar;145:1-16
pubmed: 2106820
Laryngoscope. 2012 Feb;122(2):401-8
pubmed: 22252604
Ann Otol Rhinol Laryngol. 2013 Oct;122(10):648-52
pubmed: 24294688
Clin Otolaryngol. 2014 Jun;39(3):145-9
pubmed: 24716511
J Clin Endocrinol Metab. 2015 Jun;100(6):2413-9
pubmed: 25879512
Clin Otolaryngol. 2016 Apr;41(2):149-53
pubmed: 26096174
PLoS One. 2015 Jul 14;10(7):e0132447
pubmed: 26171780
Auris Nasus Larynx. 2016 Aug;43(4):400-3
pubmed: 26656733
Clin Rheumatol. 1989 Jun;8 Suppl 2:13-5
pubmed: 2758777
Eur Arch Otorhinolaryngol. 2018 Jan;275(1):1-10
pubmed: 29043479
J Clin Invest. 1979 Sep;64(3):729-36
pubmed: 468987
J Clin Endocrinol Metab. 1980 Dec;51(6):1359-64
pubmed: 6255005
ASHA. 1981 Jul;23(7):493-500
pubmed: 7052898
Ann Epidemiol. 1995 Jan;5(1):8-14
pubmed: 7728291
J Am Audiol Soc. 1977 Mar-Apr;2(5):185-7
pubmed: 853010
Laryngoscope. 1977 Oct;87(10 Pt 1):1753-9
pubmed: 904413